Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
作者:Hui Wen、Wen Qin、Guangzhong Yang、Yanshen Guo
DOI:10.3390/molecules24030497
日期:——
To improve the in vivo antidepressant activity of previously reported serotonin (5-HT) and norepinephrine (NE) dual reuptake inhibitors, three series of arylamidine derivatives were designed and synthesized. The in vitro 5-HT and NE reuptake inhibitory activities of these compounds were evaluated, and compound II-5 was identified as the most potent 5-HT (IC50 = 620 nM) and NE (IC50 = 10 nM) dual reuptake
为了提高先前报道的5-羟色胺(5-HT)和去甲肾上腺素(NE)双重再摄取抑制剂的体内抗抑郁活性,设计并合成了三个系列的芳基idine胺衍生物。评估了这些化合物的体外5-HT和NE重摄取抑制活性,化合物II-5被确定为最有效的5-HT(IC50 = 620 nM)和NE(IC50 = 10 nM)双重重摄取抑制剂。化合物II-5在大鼠尾部悬吊试验中显示出有效的抗抑郁活性,并在小鼠的初步急性毒性试验中显示出可接受的安全性。我们的结果表明,这些芳酰胺衍生物表现出有效的5-HT / NE双重再摄取抑制作用,应作为抗抑郁药候选者进行进一步研究。